Biodegradation of polyurethanes and nanocomposites to non-cytotoxic degradation products

Abstract

Polyurethanes with controllable biodegradable properties have been considered for biomedical applications. However, the potential toxicity of their biodegraded by-products is still a concern. In this study, biodegradable polyurethanes based on poly(ɛ-caprolactone) (PCL) and/or poly(ethylene glycol) as soft segments and biodegradable polyurethanes containing montmorillonite nanoparticles were synthesized and were subjected to in vitro biodegradation for 4 months. The post-degraded polyurethanes and nanocomposites were characterized by infrared spectroscopy (FTIR), X-ray diffraction (XRD) and small angle X-ray scattering (SAXS). The toxicity of the biodegradation by-products was evaluated by measuring their effect on the viability of retinal cells. FTIR results indicated that hard segments of the biomaterials were preserved during biodegradation, and suggested that the ester bonds of the PCL incorporated into the soft segments were hydrolytic broken. XRD data indicated also that the soft segments crystallized as a result of the hydrolysis of PCL ester bonds and re-organization of the amorphous phase during annealing at 37 °C. As the biodegradation of the biomaterials induced the formation of soft segment lamella crystals, a complex nanostructure was formed, resulting in the enhancement of the small angle X-ray scattering. The by-products were non-cytotoxic to the retinal cells. These results suggest that the hydrolytic unstable polyurethanes and nanocomposites can be possible candidates for ophthalmological applications.